MUX insider Richard Brissenden receives 20,000 stock options at $10.43

Rhea-AI Filing Summary

Richard W. Brissenden, a director of McEwen Inc. (MUX), was granted a stock option that gives him the right to purchase up to 20,000 common shares at an exercise price of $10.43 per share. The option was recorded with an effective transaction date of 08/11/2025 and shows an expiration date of 08/11/2030. The grant vests in three equal annual installments beginning 08/11/2026, and the shares underlying the option are reported as directly owned by the reporting person following the transaction.

This Form 4 discloses the specific terms of the derivative award (exercise price, number of shares, vesting schedule and expiration) but does not provide information on total insider holdings relative to outstanding shares or any cash payments made in connection with the grant.

Positive

• 20,000-share option grant recorded for a company director, showing clear disclosure of the award
• Exercise price disclosed at $10.43, providing a specific strike for the option
• Vesting schedule provided: three equal annual installments beginning 08/11/2026
• Expiration date disclosed as 08/11/2030 and ownership reported as Direct

Negative

• None.

Insights

Financial Analyst

TL;DR: Director granted a 20,000-share option at $10.43, vesting over three years and expiring in 2030; impact appears routine and informational.

The filing documents a non-derivative derivative award: a stock option for 20,000 common shares with a $10.43 exercise price, recorded 08/11/2025 and expiring 08/11/2030. Vesting is specified as three equal annual installments beginning 08/11/2026, and ownership is direct. For investors, the entry is primarily a disclosure of insider compensation mechanics rather than a transaction that immediately changes outstanding share count or cash flows; the filing does not disclose the option's grant valuation or the director's total holdings relative to the company capitalization.

Corporate Governance Expert

TL;DR: This Form 4 reports a standard director equity grant with a clear vesting schedule and direct ownership; disclosure is complete on vesting and expiry.

The report identifies Richard W. Brissenden as the reporting director and records a stock option for 20,000 shares at an exercise price of $10.43. The option vests in three equal annual installments starting 08/11/2026 and carries an expiration date of 08/11/2030. The disclosure covers key governance elements of the award (amount, price, vesting, expiry, direct ownership) but does not include any contextual compensation policy or the aggregate insider positions, which limits assessment of incentive alignment from this filing alone.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Brissenden Richard W.

(Last) (First) (Middle)

C/O MCEWEN INC.

150 KING STREET WEST, SUITE 2800

(Street)

TORONTO A6 M5H 1J9

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
McEwen Inc. [ MUX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$10.43	08/11/2025		A		20,000		(1)	08/11/2030	Common Stock	20,000	$0	20,000	D

Explanation of Responses:

1. The option vests in three equal annual installments, beginning August 11, 2026.

	/s/ Richard W. Brissenden	08/13/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Richard W. Brissenden report on Form 4 for McEwen Inc. (MUX)?

He reported a stock option grant giving the right to purchase 20,000 common shares at an exercise price of $10.43.

When does the option granted to the MUX director vest?

The option vests in three equal annual installments beginning on 08/11/2026.

When does the option expire and what is the exercise price?

The option shows an expiration date of 08/11/2030 and an exercise price of $10.43 per share.

How many shares does the MUX option cover and what ownership form was reported?

The option covers 20,000 underlying common shares and is reported as Direct ownership.

Was the transaction date disclosed on the Form 4 for MUX?

Yes; the transaction date recorded in the filing is 08/11/2025.